These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 27483366)

  • 1. Anti-HIV Antibody Responses and the HIV Reservoir Size during Antiretroviral Therapy.
    Lee SA; Bacchetti P; Chomont N; Fromentin R; Lewin SR; O'Doherty U; Palmer S; Richman DD; Siliciano JD; Yukl SA; Deeks SG; Burbelo PD
    PLoS One; 2016; 11(8):e0160192. PubMed ID: 27483366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy.
    Yukl SA; Gianella S; Sinclair E; Epling L; Li Q; Duan L; Choi AL; Girling V; Ho T; Li P; Fujimoto K; Lampiris H; Hare CB; Pandori M; Haase AT; Günthard HF; Fischer M; Shergill AK; McQuaid K; Havlir DV; Wong JK
    J Infect Dis; 2010 Nov; 202(10):1553-61. PubMed ID: 20939732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of HIV-DNA and residual viremia in patients starting ART by droplet digital PCR: Their dynamic decay and correlations with immunological parameters and virological success.
    Alteri C; Scutari R; Stingone C; Maffongelli G; Brugneti M; Falasca F; Martini S; Bertoli A; Turriziani O; Sarmati L; Coppola N; Andreoni M; Santoro MM; Perno CF; Ceccherini-Silberstein F; Svicher V
    J Clin Virol; 2019 Aug; 117():61-67. PubMed ID: 31229934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of concordance between residual viremia and viral variants driving de novo infection of CD4(+) T cells on ART.
    Puertas MC; Noguera-Julian M; Massanella M; Pou C; Buzon MJ; Clotet B; Stevenson M; Paredes R; Blanco J; Martinez-Picado J
    Retrovirology; 2016 Aug; 13(1):51. PubMed ID: 27484989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies.
    Eriksson S; Graf EH; Dahl V; Strain MC; Yukl SA; Lysenko ES; Bosch RJ; Lai J; Chioma S; Emad F; Abdel-Mohsen M; Hoh R; Hecht F; Hunt P; Somsouk M; Wong J; Johnston R; Siliciano RF; Richman DD; O'Doherty U; Palmer S; Deeks SG; Siliciano JD
    PLoS Pathog; 2013 Feb; 9(2):e1003174. PubMed ID: 23459007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV DNA subspecies persist in both activated and resting memory CD4+ T cells during antiretroviral therapy.
    Murray JM; Zaunders JJ; McBride KL; Xu Y; Bailey M; Suzuki K; Cooper DA; Emery S; Kelleher AD; Koelsch KK;
    J Virol; 2014 Mar; 88(6):3516-26. PubMed ID: 24403590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atlas of the HIV-1 Reservoir in Peripheral CD4 T Cells of Individuals on Successful Antiretroviral Therapy.
    Gálvez C; Grau-Expósito J; Urrea V; Clotet B; Falcó V; Buzón MJ; Martinez-Picado J
    mBio; 2021 Dec; 12(6):e0307821. PubMed ID: 34844430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent measures of total and integrated HIV DNA monitor reservoirs and ongoing replication in eradication trials.
    Mexas AM; Graf EH; Pace MJ; Yu JJ; Papasavvas E; Azzoni L; Busch MP; Di Mascio M; Foulkes AS; Migueles SA; Montaner LJ; O'Doherty U
    AIDS; 2012 Nov; 26(18):2295-306. PubMed ID: 23014521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Different Antiretroviral Strategies on Total HIV-DNA Level in Virologically Suppressed HIV-1 Infected Patients.
    Bon I; Calza L; Musumeci G; Longo S; Bertoldi A; D'Urbano V; Gibellini D; Magistrelli E; Viale PL; Re MC
    Curr HIV Res; 2017; 15(6):448-455. PubMed ID: 29210661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infrequent HIV Infection of Circulating Monocytes during Antiretroviral Therapy.
    Massanella M; Bakeman W; Sithinamsuwan P; Fletcher JLK; Chomchey N; Tipsuk S; Chalermchai T; Routy JP; Ananworanich J; Valcour VG; Chomont N
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Immunodeficiency Virus Persistence and T-Cell Activation in Blood, Rectal, and Lymph Node Tissue in Human Immunodeficiency Virus-Infected Individuals Receiving Suppressive Antiretroviral Therapy.
    Khoury G; Fromentin R; Solomon A; Hartogensis W; Killian M; Hoh R; Somsouk M; Hunt PW; Girling V; Sinclair E; Bacchetti P; Anderson JL; Hecht FM; Deeks SG; Cameron PU; Chomont N; Lewin SR
    J Infect Dis; 2017 Mar; 215(6):911-919. PubMed ID: 28453847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual plasma viraemia and infectious HIV-1 recovery from resting memory CD4 cells in patients on antiretroviral therapy: results from ACTG A5173.
    Gandhi RT; Bosch RJ; Aga E; Bedison MA; Bastow B; Schmitz JL; Siliciano JD; Siliciano RF; Eron JJ; Mellors JW;
    Antivir Ther; 2013; 18(4):607-13. PubMed ID: 23411421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy.
    Furtado MR; Callaway DS; Phair JP; Kunstman KJ; Stanton JL; Macken CA; Perelson AS; Wolinsky SM
    N Engl J Med; 1999 May; 340(21):1614-22. PubMed ID: 10341273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of HIV reservoir decay and naïve CD4 T-cell recovery between immune non-responders and complete responders on long-term antiretroviral treatment.
    Zhang LX; Song JW; Zhang C; Fan X; Huang HH; Xu RN; Liu JY; Zhang JY; Wang LF; Zhou CB; Jin L; Shi M; Wang FS; Jiao YM
    Clin Immunol; 2021 Aug; 229():108773. PubMed ID: 34102315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4 T cell nadir independently predicts the magnitude of the HIV reservoir after prolonged suppressive antiretroviral therapy.
    Boulassel MR; Chomont N; Pai NP; Gilmore N; Sékaly RP; Routy JP
    J Clin Virol; 2012 Jan; 53(1):29-32. PubMed ID: 22019250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular HIV-1 DNA levels in patients receiving antiretroviral therapy strongly correlate with therapy initiation timing but not with therapy duration.
    Watanabe D; Ibe S; Uehira T; Minami R; Sasakawa A; Yajima K; Yonemoto H; Bando H; Ogawa Y; Taniguchi T; Kasai D; Nishida Y; Yamamoto M; Kaneda T; Shirasaka T
    BMC Infect Dis; 2011 May; 11():146. PubMed ID: 21605468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral Therapy Concentrations Differ in Gut vs. Lymph Node Tissues and Are Associated With HIV Viral Transcription by a Novel RT-ddPCR Assay.
    Lee SA; Telwatte S; Hatano H; Kashuba ADM; Cottrell ML; Hoh R; Liegler TJ; Stephenson S; Somsouk M; Hunt PW; Deeks SG; Yukl S; Savic RM
    J Acquir Immune Defic Syndr; 2020 Apr; 83(5):530-537. PubMed ID: 32168200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated and Total HIV-1 DNA Predict Ex Vivo Viral Outgrowth.
    Kiselinova M; De Spiegelaere W; Buzon MJ; Malatinkova E; Lichterfeld M; Vandekerckhove L
    PLoS Pathog; 2016 Mar; 12(3):e1005472. PubMed ID: 26938995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy.
    Gandhi RT; Cyktor JC; Bosch RJ; Mar H; Laird GM; Martin A; Collier AC; Riddler SA; Macatangay BJ; Rinaldo CR; Eron JJ; Siliciano JD; McMahon DK; Mellors JW;
    J Infect Dis; 2021 Feb; 223(2):225-233. PubMed ID: 32823274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paucity of Intact Non-Induced Provirus with Early, Long-Term Antiretroviral Therapy of Perinatal HIV Infection.
    Rainwater-Lovett K; Ziemniak C; Watson D; Luzuriaga K; Siberry G; Petru A; Chen Y; Uprety P; McManus M; Ho YC; Lamers SL; Persaud D
    PLoS One; 2017; 12(2):e0170548. PubMed ID: 28178277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.